Annual Drug Patent Expirations for RISPERDAL+CONSTA Risperdal Consta is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Janssen Pharms drug RISPERDAL CONS…
New patent expiration for Janssen Pharms drug RISPERDAL CONSTA Read Post »
Annual Drug Patent Expirations for RISPERDAL+CONSTA Risperdal Consta is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Janssen Pharms drug RISPERDAL CONS…
New patent expiration for Janssen Pharms drug RISPERDAL CONSTA Read Post »
Annual Drug Patent Expirations for ORBACTIV Orbactiv is a drug marketed by Melinta Therap and is included in one NDA. It is available from two suppliers. There are four patents…
The post New patent expiration for Melinta Therap drug ORBACTIV appeared f…
New patent expiration for Melinta Therap drug ORBACTIV Read Post »
Annual Drug Patent Expirations for TWIRLA Twirla is a drug marketed by Agile and is included in one NDA. There are eight patents protecting this drug. This drug has fifty-six…
The post New patent expiration for AGILE drug TWIRLA appeared first on DrugP…
Annual Drug Patent Expirations for DULERA Dulera is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Merck Sharp drug DULERA appeared first on DrugPate…
New patent expiration for Merck Sharp drug DULERA Read Post »
DULERA (formoterol fumarate; mometasone furoate) Merck sharp dohme Patent: 7,566,705 Expiration: Nov 21, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Patent Expiratio…
Drug Patent Expirations for the Week of November 15, 2020 Read Post »
Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Recordati Rare drug NEOPROFEN appear…
New patent expiration for Recordati Rare drug NEOPROFEN Read Post »
Annual Drug Patent Expirations for FENSOLVI+KIT Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Tolmar drug FENSOLVI KIT appeared first…
New patent expiration for Tolmar drug FENSOLVI KIT Read Post »
Annual Drug Patent Expirations for RADICAVA Radicava is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Mitsubishi Tanabe drug RADICAVA appeared…
New patent expiration for Mitsubishi Tanabe drug RADICAVA Read Post »
Annual Drug Patent Expirations for ELIGARD+KIT Eligard Kit is a drug marketed by Tolmar Therap and is included in four NDAs. It is available from one supplier. There are five…
The post New patent expiration for Tolmar Therap drug ELIGARD KIT appeared f…
New patent expiration for Tolmar Therap drug ELIGARD KIT Read Post »